You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / CE

The Relevance of Clinical Data in Dermatologic Fungus: Closing the Gaps

  • Authors: Jeffrey M. Robbins, DPM
  • CME / CE Released: 1/29/2016
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 1/29/2017
Start Activity


Target Audience and Goal Statement

This activity is intended for dermatologists, podiatrists, primary care physicians, nurses, and nurse practitioners who treat patients with onychomycosis.

The goal of this activity is to review new and emerging data relating to onychomycosis and its management.

Upon completion of this activity, participants will be able to:

  1. Summarize the latest clinical data of systemic, topical, and other treatment modalities for onychomycosis in the context of clinical decision making
  2. Individualize treatments for onychomycosis based on clinical findings
  3. Describe post-treatment management, including prevention of recurrent onychomycosis infection


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Jeffrey M. Robbins, DPM

    Professor, Podiatric Medicine, Kent State University College of Podiatric Medicine; Director, Podiatry Services VACO, Independence, Ohio

    Disclosures

    Disclosure: Jeffrey M. Robbins, DPM, has disclosed no relevant financial relationships.

    Dr Robbins does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Robbins does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Steering Committee

  • Boni E. Elewski, MD (Chair)

    Professor, University of Alabama, Birmingham

    Disclosures

    Disclosure: Boni E. Elewski, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Anacor Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Valeant Pharmaceuticals International
    Received grants for clinical research from: AbbVie Inc; Amgen, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Valeant Pharmaceuticals International

  • Aditya K. Gupta, MD, PhD, FRCPC, FAAD, MBA

    Professor, University of Toronto, Toronto, Ontario

    Disclosures

    Disclosure: Aditya K. Gupta, MD, PhD, FRCPC, FAAD, MBA, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Anacor Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Moberg Pharma; Valeant Pharmaceuticals International
    Received grants for clinical research from: Valeant Pharmaceuticals International
    Clinical trials investigator: Lilly; Merck & Co., Inc.; UCB Pharma, Inc.

  • Antonella Tosti, MD

    Professor, Department of Dermatology & Cutaneous Surgery, University of Miami, Miami, Florida

    Disclosures

    Disclosure: Antonella Tosti, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Anacor Pharmaceuticals, Inc.; PharmaDerm; Polichem; Valeant Pharmaceuticals International; Viamet Pharmaceuticals Holdings, LLC
    Served as a speaker or a member of a speakers bureau for: PharmDerm; Sandoz

  • Tracey C. Vlahovic, DPM, FFPM RCPS (Glasg)

    Associate Professor, Temple University School of Podiatric Medicine, Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Tracey C. Vlahovic, DPM, FFPM, RCPS (Glasg), has disclosed the following relevant financial relationships:
    Served as a speaker or a member of a speakers bureau for: Pharmaderm; Valeant Pharmaceuticals International

  • Dyanne P. Westerberg, DO

    Associate Professor, Cooper Medical School of Rowan University, Camden, New Jersey

    Disclosures

    Disclosure: Dyanne P. Westerberg, DO, has disclosed no relevant financial relationships.

Editors

  • Shari J. Dermer, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Shari J. Dermer, PhD, has disclosed no relevant financial relationships.

  • Eileen A. McCaffrey, MA

    Freelance Medical Writer, Whippany, New Jersey

    Disclosures

    Disclosure: Eileen A. McCaffrey, MA, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

CME Reviewer

  • Robert Eckles, DPM, MPH

    Dean, Clinical and Graduate Medical Education Associate Professor, Department of Orthopedic Sciences, New York College of Podiatric Medicine

    Disclosures

    Disclosure: Robert Eckles, DPM, MPH, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medscape, LLC and New York College of Podiatric Medicine. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC Staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

    Contact This Provider

  • For Podiatrists

    This activity has been planned and implemented in accordance with the standards and requirements for approval of providers of continuing education in podiatric medicine through a joint provider agreement between New York College of Podiatric Medicine and Medscape, LLC. New York College of Podiatric Medicine is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. New York College of Podiatric Medicine has approved this activity for a maximum of 1.0 continuing education contact hours.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

The Relevance of Clinical Data in Dermatologic Fungus: Closing the Gaps

Authors: Jeffrey M. Robbins, DPMFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / CE Released: 1/29/2016

Valid for credit through: 1/29/2017

processing....

Introduction

Onychomycosis is a fungal infection of the nails that is common, communicable, frequently relapsing and recurring, and difficult to cure. Some clinicians incorrectly view the infection as not worthy of treatment. Yet onychomycosis can lead to serious consequences, especially in certain populations. Many factors that predispose to risk of infection also can reduce the likelihood of treatment response. Accumulating evidence suggests that genetic mutations along with older age, male sex, and various other comorbidities are associated with susceptibility to infection.

Two topical treatments have been recently introduced. The choice of pharmacologic therapy should consider infection severity, presence of comorbid conditions, potential drug-drug interactions, history of prior nail infection, factors predicting treatment response, and patient viewpoint. A sometimes neglected aspect of management is the careful follow-up and patient education needed to reduce the risk of reinfection and recurrence.

Educational Impact Challenge

Assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print